NMC Health share price up 8% after hiring former FBI director to review Muddy Waters allegations
The healthcare provider saw its shares climb higher after announcing its appointment of former Federal Judge and FBI director Louis Freeh to review allegations of financial wrongdoing.
NMC Health shares climbed 8% higher on Friday morning after the company announced it had hired former Federal Judge and FBI director Louis Freeh and his firm to review allegations of financial wrongdoing by short seller Muddy Waters.
The healthcare provider saw its shares fall by 44% since Muddy Waters published a report on 17 December that cast doubts about its finances and asset valuations.
‘The Committee chose Freeh Group to provide a completely independent, unbiased, comprehensive and transparent report that will address all of these allegations,’ said Jonathan Bomford, Chairman of the Independent Review Committee.
The Committee intends to publish findings of the review into all primary allegations made, particularly all those of a financial nature, in advance of the release of the company’s 2019 financial results.
NMC Health is trading at £15.24 as of 11:30 GMT on Friday.
Looking to trade NMC Health? Open a live or demo account with IG.
Barclays Capital reiterates ‘overweight’ rating for NMC Health
Analysts from Barclays Capital believe the stock is better value than its peers, reiterating its ‘overweight’ rating for NMC Health in January.
The investment bank has left its target price of £42.75 for the stock unchanged since August last year, implying the NMC Health has a potential upside 181.25%.
You can go long or short NMC Health with IG using derivatives like CFDs.
This information has been prepared by IG, a trading name of IG Markets Ltd and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only
